BioSpace News Archive

Pacgen Announces Private Placement Financing and Appointment of New Director

Proceeds from the private placement will be used for business development and general corporate purposes.

January 11, 2018
·
4 min read
Business

Endonovo Therapeutics Engages ShareIntel, A Leader in Shareholder Intelligence Services to Investigate Market Maker and Clearing Firm Irregularities

This will enable Endonovo to proactively track equity flows, identify parties to suspicious, aberrant and/or unusual trading activity and deploy action steps to help curtail such activity.

January 11, 2018
·
3 min read
Hemispherx Enhances Manufacturing Efficiency of Ampligen

The manufacture of Ampligen, a double-stranded RNA, requires an enzyme which historically has been difficult to prepare.

January 11, 2018
·
3 min read
Drug Development

Renova Therapeutics to Present Key Components of FLOURISH Gene Therapy Trial for the Treatment of Heart Failure at Keystone Symposium

Renova announced today that it will present an overview of its RT-100 AC6 gene transfer Phase 3 clinical trial in a poster session at the Keystone Symposium on Heart Failure on January 14-18, 2018, in Keystone, Colorado.

January 11, 2018
·
3 min read
Business

Concept Life Sciences Appoints Helen McKeever as Group Programme Manager and David Halverson as US Head of Sales

Helen joins Concept from RedX Pharma where she was Project Manager, leading a portfolio of small molecule projects from late discovery to early clinical development.

January 11, 2018
·
2 min read
Pharm Country

Rgenix Announces Publication In Cell Demonstrating Activation of LXR/ApoE with RGX-104 Enhances Antitumor Immunity

Rgenix announced today the publication of clinical and pre-clinical results by research collaborators at Rgenix and The Rockefeller University.

January 11, 2018
·
3 min read
Business

Premier Biomedical and HealthWarehouse Team Up to Fight Opioid Pain Medication Abuse

The agreement covers not only Premier’s existing five pain relief products, but also those planned for the future.

January 11, 2018
·
4 min read
Business

Immunomedics Announces Agreement With University of Wisconsin Carbone Cancer Center to Expand Sacituzumab Govitecan (IMMU-132) Into Prostate Cancer

The Prostate Cancer Clinical Trials Consortium, to investigate Immunomedics’ lead antibody-drug conjugate product candidate, sacituzumab govitecan, in an investigator-sponsored Phase 2 trial in patients with advanced castration-resistant prostate cancer.

January 11, 2018
·
5 min read
Business

NANOBIOTIX Partners With the Providence Cancer Institute to Run Immunotherapeutic Preclinical Research in Pancreatic Cancers

The collaboration with Providence Cancer Institute will provide essential preclinical data on the ability of NBTXR3 activated by radiotherapy to induce an antitumoral immune response.

January 11, 2018
·
6 min read
Drug Development

ASIT Biotech is Publishing a New Article on the Clinical Result of gp-ASIT+T in the Prestigious Science Journal ALLERGY

ALLERGY is the official journal of the European Academy of Allergy and Clinical Immunology (EAACI).

January 11, 2018
·
1 min read